Inhibition of Mcl-1 Enhances the Efficacy of Tyrosine Kinase Inhibition in FLT3 Mutated AML and Synergizes with Venetoclax Targeting AML Stem Cells

被引:0
|
作者
Carter, Bing Z. [1 ]
Tao, Wenjing [1 ]
Mak, Po Yee [1 ]
Zhang, Qi [2 ]
Wang, Xiangmeng [1 ]
Kuruvilla, Vinitha Mary [3 ]
Stewart, Carli [2 ]
Ruvolo, Vivian [1 ]
Battula, Venkata Lokesh [1 ]
Konopleva, Marina Y. [1 ]
Caenepeel, Sean [4 ]
Canon, Jude [4 ]
Hughes, Paul [4 ]
Morrow, P. K. [4 ]
Andreeff, Michael [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Sect Mol Hematol & Therapy, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[4] Amgen Inc, Thousand Oaks, CA 91320 USA
关键词
D O I
10.1182/blood-2019-125725
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1267
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Defined niche conditions and a stem cell phenotype both contribute to the in vitro resistance of primary AML cells to a FLT3 tyrosine kinase inhibitor
    Pallis, M.
    Seedhouse, C. H.
    Russell, N. H.
    Mony, U.
    Jawad, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 13 - 13
  • [42] Targeting of MDS and AML Stem Cells Via Inhibition of STAT3 By Pyrimethamine
    Shastri, Aditi
    Schinke, Carolina
    Yanovsky, Asya Varshavsky
    Bhagat, Tushar D.
    Giricz, Orsolya
    Barreyro, Laura
    Boultwood, Jacqueline
    Pellagati, Andrea
    Yu, Yiting
    Brown, Jennifer R.
    Frank, David A.
    Das, Bhaskar
    Kambhampati, Suman
    Will, Britta
    Steidl, Ulrich
    Verma, Amit
    BLOOD, 2014, 124 (21)
  • [43] All-trans retinoic acid synergizes with FLT3 inhibition to eliminate FLT3/ITD+ leukemia stem cells in vitro and in vivo
    Ma, Hayley S.
    Greenblatt, Sarah M.
    Shirley, Courtney M.
    Duffield, Amy S.
    Bruner, J. Kyle
    Li, Li
    Bao Nguyen
    Jung, Eric
    Aplan, Peter D.
    Ghiaur, Gabriel
    Jones, Richard J.
    Small, Donald
    BLOOD, 2016, 127 (23) : 2867 - 2878
  • [44] The protein tyrosine kinase inhibitor SU5614 inhibits FLT3 and induces growth arrest and apoptosis in AML cells expressing a constitutively activated FLT3
    Dirschinger, RJ
    Schwab, R
    Faber, F
    Buske, C
    Schnittger, S
    Kelly, LM
    Gilliland, DG
    Hiddemann, W
    Spiekermann, K
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S83 - S84
  • [45] Combinatorial Targeting of Leukemia and Stromal Cells Overcomes Fms-like Tyrosine Kinase 3 (FLT3) Inhibitor Resistance in Acute Myeloid Leukemia (AML)
    Bhattacharya, Seemana
    Mu, Hong
    Piya, Sujan
    Zhang, Weiguo
    McQueen, Teresa
    Paradiso, Linda
    Oberkovitz, Galia
    Benami, Eyal
    Andreeff, Michael
    Borthakur, Gautam
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S273 - S273
  • [46] FLT3 and KIT mutated pediatric acute myeloid leukemia (AML) samples are sensitive in vitro to the tyrosine kinase inhibitor SU11657
    Goemans, Bianca F.
    Zwaan, Christian M.
    Cloos, Jacqueline
    de Lange, Desiree
    Loonen, Anne H.
    Reinhardt, Dirk
    Hahlen, Karel
    Gibson, Brenda E. S.
    Creutzig, Ursula
    Kaspers, Gertjan J. L.
    LEUKEMIA RESEARCH, 2010, 34 (10) : 1302 - 1307
  • [47] ATRA can enhance apoptosis that is induced by Flt3 tyrosine kinase inhibition in Flt3-ITD positive cells
    Scholl, S
    Müller, R
    Clement, JH
    Loncarevic, IF
    Böhmer, FD
    Höffken, K
    LEUKEMIA RESEARCH, 2006, 30 (05) : 633 - 642
  • [48] Discovery of a highly selective FLT3 inhibitor with specific proliferation inhibition against AML cells harboring FLT3-ITD mutation
    Heng, Hao
    Zhi, Yanle
    Yuan, Haoliang
    Wang, Zhijie
    Li, Hongmei
    Wang, Shuxian
    Tian, Jieyi
    Liu, Haichun
    Chen, Yadong
    Lu, Tao
    Ran, Ting
    Lu, Shuai
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 163 : 195 - 206
  • [49] Combination Therapy of FLT3 Tyrosine Kinase Inhibitors and BH3 Mimetics Targeting Antiapoptotic MCL-1 Synergistically Eliminates FLT3-ITD Acute Myeloid Leukemia Cells in Vitro and In Vivo
    Skwarska, Anna
    Moujalled, Donia M.
    Panis, Paul F.
    Patel, Shraddha
    Zhang, Qi
    Herbrich, Shelley
    Kurvilla, Vinitha
    Baran, Natalia
    Pomilio, Giovanna
    Halilovic, Ensar
    Mistry, Prakash
    Ruvolo, Vivian
    Ruvolo, Peter P.
    Derreal, Alix
    Banquet, Sebastien
    Niemira, Magdalena
    Kretowski, Adam
    Daver, Naval
    Andreeff, Michael
    Wei, Andrew H.
    Konopleva, Marina
    BLOOD, 2021, 138
  • [50] miR-9 Enhances the Chemosensitivity of AML Cells to Daunorubicin by Targeting the ElF5A2/MCL-1 Axis
    Liu, Yanhui
    Lei, Pingchong
    Qiao, Hong
    Sun, Kai
    Lu, Xiling
    Bao, Fengchang
    Cheng, Runhong
    Lian, Cheng
    Wei, Yao
    Chen, Wei
    Xue, Fei
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2019, 15 (03): : 579 - 586